| A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs) (NCT01868542) | Novo Nordisk A/S | 2013-06-01 |
| PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients (NCT01856595) | Pfizer | 2013-05-13 |
| An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes (NCT01817777) | GlaxoSmithKline | 2013-05-01 |
| A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy (NCT01871415) | Hoffmann-La Roche | 2013-05-01 |
| Insulin Sensitivity, Irisin and Adipokines as Outcome Parameters in Patients Undergoing Cardiac Surgery (NCT02258698) | University Hospital, Basel, Switzerland | 2013-05-01 |
| Clinical Trial on Diabetes Expert Patients Programme (NCT01898702) | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 2013-05-01 |
| Technology Intensified Diabetes Education Study in African Americans (NCT02088658) | State University of New York at Buffalo | 2013-05-01 |
| Lifestyle Modification for Type 2 Diabetes Involving Reduction of After-meal Blood Glucose Elevations (NCT02432391) | University of Virginia | 2013-05-01 |
| Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy (NCT01811485) | Novartis Pharmaceuticals | 2013-05-01 |
| mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot Study (NCT02081586) | University of Pittsburgh | 2013-05-01 |
| Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects (NCT01866748) | Novo Nordisk A/S | 2013-05-01 |
| The Diabetes Medication Choice Cards Trial in Greece (NCT01861756) | Aristotle University Of Thessaloniki | 2013-05-01 |
| Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes. (NCT01839344) | Bastyr University | 2013-05-01 |
| Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy (NCT01847937) | Aarhus University Hospital | 2013-05-01 |
| Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients. (NCT03088670) | SatRx LLC | 2013-04-23 |
| Southeastern Diabetes Initiative Clinical Intervention (NCT01965639) | Duke University | 2013-04-01 |
| Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects (NCT01807377) | Pfizer | 2013-04-01 |
| Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes (NCT01829477) | Takeda | 2013-04-01 |
| Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus Patients (NCT01582243) | Novartis Pharmaceuticals | 2013-04-01 |
| OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck. (NCT01842620) | GlaxoSmithKline | 2013-03-13 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects (NCT01809184) | Novo Nordisk A/S | 2013-03-04 |
| A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components (NCT01780051) | Dalim BioTech Co., Ltd. | 2013-03-01 |
| A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes (NCT01790438) | Eli Lilly and Company | 2013-03-01 |
| Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin Secretion (NCT02397447) | University of Guadalajara | 2013-03-01 |
| Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico (NCT02549495) | Brigham and Women's Hospital | 2013-03-01 |
| Development and Validation of a Self-administered QUestionnaire to Identify Levers of Adhesion Behavior to Patient's Medication in Order to Adapt the Educational Monitoring. (NCT02865525) | University Hospital, Grenoble | 2013-03-01 |
| A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily (NCT01814137) | Novo Nordisk A/S | 2013-03-01 |
| A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus (NCT01789788) | Hoffmann-La Roche | 2013-03-01 |
| A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes (NCT01796366) | Novo Nordisk A/S | 2013-02-21 |
| Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes (NCT01720446) | Novo Nordisk A/S | 2013-02-21 |
| A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin (NCT01713530) | Novo Nordisk A/S | 2013-02-21 |
| Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes (NCT01734785) | Boehringer Ingelheim | 2013-02-08 |
| Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function (NCT01790308) | Sun Yat-sen University | 2013-02-01 |
| Diabetes Screening & Prevention for People With Learning (Intellectual) Disabilities:STOP Diabetes Study (NCT02513277) | University of Leicester | 2013-02-01 |
| Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus (NCT02068989) | Yale University | 2013-02-01 |
| Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes (NCT01774968) | Eli Lilly and Company | 2013-02-01 |
| A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT01733758) | GlaxoSmithKline | 2013-02-01 |
| MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin (NCT01792518) | Boehringer Ingelheim | 2013-02-01 |
| Glucose Homeostasis and Incretin Effect T2DM in the Youth- a Study of the Malaysian Population (NCT02845557) | RCSI & UCD Malaysia Campus | 2013-02-01 |
| A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031) (NCT01767688) | Merck Sharp & Dohme LLC | 2013-01-16 |
| Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes (NCT01778049) | Boehringer Ingelheim | 2013-01-01 |
| Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin (NCT02177643) | University of Campinas, Brazil | 2013-01-01 |
| Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin (NCT03208309) | ANS Pharma | 2013-01-01 |
| Clinical and Microbiological Evaluation of Periodontal Treatment of Diabetic Patients: A Longitudinal Study (NCT02643771) | Eduardo Aleixo Figueira | 2013-01-01 |
| A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes (NCT01780272) | Novo Nordisk A/S | 2013-01-01 |
| Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes (NCT01652716) | AstraZeneca | 2013-01-01 |
| Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study (NCT02081573) | University of Pittsburgh | 2013-01-01 |
| Posterior Narrow Diameter Implants in Hyperglycemic and Normo-glycemic Patients (NCT04630691) | University of Witten/Herdecke | 2012-12-01 |
| A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin (NCT01729403) | Hoffmann-La Roche | 2012-12-01 |
| Web-based Insulin Titration - An Efficacy Study (NCT01715090) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2012-12-01 |
| A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus (NCT01792635) | Pfizer | 2012-12-01 |
| Periodontal Treatment and Glycemic Control (NCT01901926) | Pakistan Institute of Medical Sciences | 2012-12-01 |
| A Study of LY2922470 in Healthy Participants and Participants With Diabetes (NCT01746017) | Eli Lilly and Company | 2012-12-01 |
| Use of iPro™2 in Real Life Diabetes Management of Type 2 Patients in India (NCT01995539) | Medtronic MiniMed, Inc. | 2012-12-01 |
| A Study of LY2922083 in Healthy Participants and Participants With Diabetes (NCT01748552) | Eli Lilly and Company | 2012-12-01 |
| A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy (NCT01691989) | Hoffmann-La Roche | 2012-12-01 |
| A Single Dose Study of LY2605541 in Participants With Liver Impairment (NCT01751399) | Eli Lilly and Company | 2012-12-01 |
| Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a Day (NCT01234597) | Sanofi | 2012-12-01 |
| Korean Post-marketing Surveillance for Kombiglyze XR® (NCT01754142) | AstraZeneca | 2012-11-24 |
| A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus (NCT01707147) | Boehringer Ingelheim | 2012-11-16 |
| Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes (NCT01541215) | Novo Nordisk A/S | 2012-11-13 |
| A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy (NCT01691755) | Hoffmann-La Roche | 2012-11-01 |
| Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes (NCT02368704) | Assistance Publique - Hôpitaux de Paris | 2012-11-01 |
| Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function (NCT01686932) | Novartis Pharmaceuticals | 2012-11-01 |
| Telehealth Remote Patient Monitoring Study in People With Type 2 Diabetes (NCT01715649) | Sutter Health | 2012-11-01 |
| Minimal Psychological Intervention in Diabetes Patients (NCT02473081) | National Cheng-Kung University Hospital | 2012-10-01 |
| A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease (NCT01680978) | Hoffmann-La Roche | 2012-10-01 |
| Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes (NCT01719003) | Boehringer Ingelheim | 2012-10-01 |
| A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone (NCT01691846) | Hoffmann-La Roche | 2012-10-01 |
| Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation) (NCT01703286) | Boehringer Ingelheim | 2012-10-01 |
| Automated SMS-Based Appointment Validation Tool (NCT01671189) | Medic Mobile | 2012-10-01 |
| The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification (NCT01664247) | Novo Nordisk A/S | 2012-10-01 |
| Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients (NCT01708902) | Boehringer Ingelheim | 2012-10-01 |
| A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy (NCT01649297) | Boehringer Ingelheim | 2012-10-01 |
| Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects (NCT01757756) | Pfizer | 2012-10-01 |
| A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus (NCT01655186) | Biogen | 2012-09-30 |
| Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers (NCT01725672) | GlaxoSmithKline | 2012-09-27 |
| Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes (NCT01686945) | Novo Nordisk A/S | 2012-09-19 |
| Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects (NCT01690169) | Novo Nordisk A/S | 2012-09-14 |
| An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes (NCT01696266) | Novo Nordisk A/S | 2012-09-05 |
| Clinical Evaluation of BD NEXT Pen Needle (NCT01852136) | Becton, Dickinson and Company | 2012-09-01 |
| Glucagon-like Peptide (GLP) Utilization and Safety (NCT01767389) | GlaxoSmithKline | 2012-09-01 |
| A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community (NCT01695278) | Northwestern University | 2012-09-01 |
| Effects of Legume Consumption on Adiponectin and Inflammatory Markers Among Adults (NCT01906086) | Isfahan University of Medical Sciences | 2012-09-01 |
| The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism (NCT01477957) | German Diabetes Center | 2012-09-01 |
| Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2 (NCT01741181) | Tan Tock Seng Hospital | 2012-09-01 |
| The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes (NCT01617434) | Novo Nordisk A/S | 2012-09-01 |
| Effects of Legume Intake on Cardiovascular Risk Factors Among Adults at Risk for Diabetes (NCT01906099) | Isfahan University of Medical Sciences | 2012-09-01 |
| Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine (NCT01680341) | Novo Nordisk A/S | 2012-08-31 |
| The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy (NCT01618162) | Novo Nordisk A/S | 2012-08-29 |
| The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (NCT01676116) | Novo Nordisk A/S | 2012-08-29 |
| Smartphone Application for Type 2 Diabetes (NCT03468283) | Kangbuk Samsung Hospital | 2012-08-07 |
| To Evaluate Clinical Outcome and Injection Compliance of Scilin (NCT01588639) | Bayer | 2012-08-01 |
| A Study of Dulaglutide in Chinese Participants (NCT01667900) | Eli Lilly and Company | 2012-08-01 |
| Understanding and Appraising the New Medicine Service in England (NCT01635361) | University of Nottingham | 2012-08-01 |
| Chronic Effects of Two Aerobic-training Models Performed in Water and on Dry Land in Patients With Type 2 Diabetes Mellitus (T2DM). (NCT01956357) | Hospital de Clinicas de Porto Alegre | 2012-08-01 |
| Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations (NCT01680328) | Novo Nordisk A/S | 2012-08-01 |
| Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients (NCT01776788) | The First Affiliated Hospital of Xiamen University | 2012-08-01 |
| The SMART-ORACLE Study (NCT01932671) | UMC Utrecht | 2012-08-01 |
| Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus (NCT01650259) | Boehringer Ingelheim | 2012-07-23 |